Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy
Background: Diabetes is associated with an increased risk of colorectal cancer (CRC). We conducted a retrospective analysis of adenoma detection rates (ADR) in initial screening colonoscopies to further investigate the role of diabetes in adenoma detection. Methods: A chart review was performed on i...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2020-05, Vol.10 (1), p.7793-7793, Article 7793 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7793 |
---|---|
container_issue | 1 |
container_start_page | 7793 |
container_title | Scientific reports |
container_volume | 10 |
creator | Ottaviano, Lorenzo F. Li, Xueying Murray, Matthew Frye, Jesse T. Lung, Brandon E. Zhang, Ying Yi Yang, Jie Taub, Erin M. Bucobo, Juan Carlos Buscaglia, Jonathan M. Li, Ellen Miller, Joshua D. |
description | Background: Diabetes is associated with an increased risk of colorectal cancer (CRC). We conducted a retrospective analysis of adenoma detection rates (ADR) in initial screening colonoscopies to further investigate the role of diabetes in adenoma detection. Methods: A chart review was performed on initial average risk screening colonoscopies (ages 45–75) during 2012–2015. Data collected included basic demographics, insurance, BMI, family history of CRC, smoking, diabetes, and aspirin use. Multivariable generalized linear mixed models for binary outcomes were used to examine the relationship between diabetes and variables associated with CRC risk and ADR. Results: Of 2865 screening colonoscopies, 282 were performed on patients with type 2 diabetes (T2DM). Multivariable analysis suggested that T2DM (OR = 1.49, 95% CI:1.13–1.97, p = 0.0047) was associated with an increased ADR, as well as smoking, older age, higher BMI and male sex (all p |
doi_str_mv | 10.1038/s41598-020-64344-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7210255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2400097799</sourcerecordid><originalsourceid>FETCH-LOGICAL-c588t-31083c584a0a5ed34526091e8690e5c0c9a50e1abb696b1e52d6ec212f39715a3</originalsourceid><addsrcrecordid>eNp9kU1LxDAQhoMoKuof8CAFL16qySTpNhdBxC9QvOg5pOnsGmmTmnSF_ffGXb8PzmUG5pl3MnkJ2Wf0mFFenyTBpKpLCrSsBBeihDWyDVTIEjjA-o96i-yl9ExzSFCCqU2yxYHXkgu-Te4eFgMWULTONDhiKlw_GDumwoYuRLSj6QrTog-9KdoM2NEFXzhfJBsRvfOzJelDsmFY7JKNqekS7n3kHfJ4efFwfl3e3l_dnJ_dllbW9VhyRmueS2GokdhyIaGiimFdKYrSUquMpMhM01SqahhKaCu0wGDK1YRJw3fI6Up3mDc9thb9GE2nh-h6Exc6GKd_d7x70rPwqifAKEiZBY4-BGJ4mWMade-Sxa4zHsM8aRD5t3jFFM3o4R_0Ocyjz-ctKaomE6UyBSvKxpBSxOnXYxjV74bplWE6G6aXhmnIQwc_z_ga-bQnA3wFpNzyM4zfu_-RfQPdRqCj</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2400097799</pqid></control><display><type>article</type><title>Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Ottaviano, Lorenzo F. ; Li, Xueying ; Murray, Matthew ; Frye, Jesse T. ; Lung, Brandon E. ; Zhang, Ying Yi ; Yang, Jie ; Taub, Erin M. ; Bucobo, Juan Carlos ; Buscaglia, Jonathan M. ; Li, Ellen ; Miller, Joshua D.</creator><creatorcontrib>Ottaviano, Lorenzo F. ; Li, Xueying ; Murray, Matthew ; Frye, Jesse T. ; Lung, Brandon E. ; Zhang, Ying Yi ; Yang, Jie ; Taub, Erin M. ; Bucobo, Juan Carlos ; Buscaglia, Jonathan M. ; Li, Ellen ; Miller, Joshua D.</creatorcontrib><description>Background: Diabetes is associated with an increased risk of colorectal cancer (CRC). We conducted a retrospective analysis of adenoma detection rates (ADR) in initial screening colonoscopies to further investigate the role of diabetes in adenoma detection. Methods: A chart review was performed on initial average risk screening colonoscopies (ages 45–75) during 2012–2015. Data collected included basic demographics, insurance, BMI, family history of CRC, smoking, diabetes, and aspirin use. Multivariable generalized linear mixed models for binary outcomes were used to examine the relationship between diabetes and variables associated with CRC risk and ADR. Results: Of 2865 screening colonoscopies, 282 were performed on patients with type 2 diabetes (T2DM). Multivariable analysis suggested that T2DM (OR = 1.49, 95% CI:1.13–1.97, p = 0.0047) was associated with an increased ADR, as well as smoking, older age, higher BMI and male sex (all p < 0.05). For patients with T2DM, those not taking diabetes medications were more likely to have an adenoma than those taking medication (OR = 2.38, 95% CI:1.09–5.2, p = 0.03). Conclusion: T2DM has an effect on ADR after controlling for multiple confounding variables. Early interventions for prevention of T2DM and prescribing anti-diabetes medications may reduce development of colonic adenomas and may contribute to CRC prevention.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-020-64344-2</identifier><identifier>PMID: 32385343</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/163/2743/137 ; 692/4020/1503/1504/1885 ; Adenoma ; Adenoma - complications ; Adenoma - diagnosis ; Adenoma - epidemiology ; Aged ; Aspirin ; Colonoscopy ; Colonoscopy - methods ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms - complications ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - epidemiology ; Demography ; Diabetes ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - epidemiology ; Early Detection of Cancer ; Female ; Genetics ; Humanities and Social Sciences ; Humans ; Male ; Mass Screening ; Middle Aged ; multidisciplinary ; Neoplasm Staging ; Odds Ratio ; Prevention ; Science ; Science (multidisciplinary) ; Smoking ; Tumors</subject><ispartof>Scientific reports, 2020-05, Vol.10 (1), p.7793-7793, Article 7793</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c588t-31083c584a0a5ed34526091e8690e5c0c9a50e1abb696b1e52d6ec212f39715a3</citedby><cites>FETCH-LOGICAL-c588t-31083c584a0a5ed34526091e8690e5c0c9a50e1abb696b1e52d6ec212f39715a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210255/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210255/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,41120,42189,51576,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32385343$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ottaviano, Lorenzo F.</creatorcontrib><creatorcontrib>Li, Xueying</creatorcontrib><creatorcontrib>Murray, Matthew</creatorcontrib><creatorcontrib>Frye, Jesse T.</creatorcontrib><creatorcontrib>Lung, Brandon E.</creatorcontrib><creatorcontrib>Zhang, Ying Yi</creatorcontrib><creatorcontrib>Yang, Jie</creatorcontrib><creatorcontrib>Taub, Erin M.</creatorcontrib><creatorcontrib>Bucobo, Juan Carlos</creatorcontrib><creatorcontrib>Buscaglia, Jonathan M.</creatorcontrib><creatorcontrib>Li, Ellen</creatorcontrib><creatorcontrib>Miller, Joshua D.</creatorcontrib><title>Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Background: Diabetes is associated with an increased risk of colorectal cancer (CRC). We conducted a retrospective analysis of adenoma detection rates (ADR) in initial screening colonoscopies to further investigate the role of diabetes in adenoma detection. Methods: A chart review was performed on initial average risk screening colonoscopies (ages 45–75) during 2012–2015. Data collected included basic demographics, insurance, BMI, family history of CRC, smoking, diabetes, and aspirin use. Multivariable generalized linear mixed models for binary outcomes were used to examine the relationship between diabetes and variables associated with CRC risk and ADR. Results: Of 2865 screening colonoscopies, 282 were performed on patients with type 2 diabetes (T2DM). Multivariable analysis suggested that T2DM (OR = 1.49, 95% CI:1.13–1.97, p = 0.0047) was associated with an increased ADR, as well as smoking, older age, higher BMI and male sex (all p < 0.05). For patients with T2DM, those not taking diabetes medications were more likely to have an adenoma than those taking medication (OR = 2.38, 95% CI:1.09–5.2, p = 0.03). Conclusion: T2DM has an effect on ADR after controlling for multiple confounding variables. Early interventions for prevention of T2DM and prescribing anti-diabetes medications may reduce development of colonic adenomas and may contribute to CRC prevention.</description><subject>692/163/2743/137</subject><subject>692/4020/1503/1504/1885</subject><subject>Adenoma</subject><subject>Adenoma - complications</subject><subject>Adenoma - diagnosis</subject><subject>Adenoma - epidemiology</subject><subject>Aged</subject><subject>Aspirin</subject><subject>Colonoscopy</subject><subject>Colonoscopy - methods</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms - complications</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - epidemiology</subject><subject>Demography</subject><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Early Detection of Cancer</subject><subject>Female</subject><subject>Genetics</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Middle Aged</subject><subject>multidisciplinary</subject><subject>Neoplasm Staging</subject><subject>Odds Ratio</subject><subject>Prevention</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Smoking</subject><subject>Tumors</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kU1LxDAQhoMoKuof8CAFL16qySTpNhdBxC9QvOg5pOnsGmmTmnSF_ffGXb8PzmUG5pl3MnkJ2Wf0mFFenyTBpKpLCrSsBBeihDWyDVTIEjjA-o96i-yl9ExzSFCCqU2yxYHXkgu-Te4eFgMWULTONDhiKlw_GDumwoYuRLSj6QrTog-9KdoM2NEFXzhfJBsRvfOzJelDsmFY7JKNqekS7n3kHfJ4efFwfl3e3l_dnJ_dllbW9VhyRmueS2GokdhyIaGiimFdKYrSUquMpMhM01SqahhKaCu0wGDK1YRJw3fI6Up3mDc9thb9GE2nh-h6Exc6GKd_d7x70rPwqifAKEiZBY4-BGJ4mWMade-Sxa4zHsM8aRD5t3jFFM3o4R_0Ocyjz-ctKaomE6UyBSvKxpBSxOnXYxjV74bplWE6G6aXhmnIQwc_z_ga-bQnA3wFpNzyM4zfu_-RfQPdRqCj</recordid><startdate>20200508</startdate><enddate>20200508</enddate><creator>Ottaviano, Lorenzo F.</creator><creator>Li, Xueying</creator><creator>Murray, Matthew</creator><creator>Frye, Jesse T.</creator><creator>Lung, Brandon E.</creator><creator>Zhang, Ying Yi</creator><creator>Yang, Jie</creator><creator>Taub, Erin M.</creator><creator>Bucobo, Juan Carlos</creator><creator>Buscaglia, Jonathan M.</creator><creator>Li, Ellen</creator><creator>Miller, Joshua D.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200508</creationdate><title>Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy</title><author>Ottaviano, Lorenzo F. ; Li, Xueying ; Murray, Matthew ; Frye, Jesse T. ; Lung, Brandon E. ; Zhang, Ying Yi ; Yang, Jie ; Taub, Erin M. ; Bucobo, Juan Carlos ; Buscaglia, Jonathan M. ; Li, Ellen ; Miller, Joshua D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c588t-31083c584a0a5ed34526091e8690e5c0c9a50e1abb696b1e52d6ec212f39715a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>692/163/2743/137</topic><topic>692/4020/1503/1504/1885</topic><topic>Adenoma</topic><topic>Adenoma - complications</topic><topic>Adenoma - diagnosis</topic><topic>Adenoma - epidemiology</topic><topic>Aged</topic><topic>Aspirin</topic><topic>Colonoscopy</topic><topic>Colonoscopy - methods</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms - complications</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - epidemiology</topic><topic>Demography</topic><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Early Detection of Cancer</topic><topic>Female</topic><topic>Genetics</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Middle Aged</topic><topic>multidisciplinary</topic><topic>Neoplasm Staging</topic><topic>Odds Ratio</topic><topic>Prevention</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Smoking</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ottaviano, Lorenzo F.</creatorcontrib><creatorcontrib>Li, Xueying</creatorcontrib><creatorcontrib>Murray, Matthew</creatorcontrib><creatorcontrib>Frye, Jesse T.</creatorcontrib><creatorcontrib>Lung, Brandon E.</creatorcontrib><creatorcontrib>Zhang, Ying Yi</creatorcontrib><creatorcontrib>Yang, Jie</creatorcontrib><creatorcontrib>Taub, Erin M.</creatorcontrib><creatorcontrib>Bucobo, Juan Carlos</creatorcontrib><creatorcontrib>Buscaglia, Jonathan M.</creatorcontrib><creatorcontrib>Li, Ellen</creatorcontrib><creatorcontrib>Miller, Joshua D.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ottaviano, Lorenzo F.</au><au>Li, Xueying</au><au>Murray, Matthew</au><au>Frye, Jesse T.</au><au>Lung, Brandon E.</au><au>Zhang, Ying Yi</au><au>Yang, Jie</au><au>Taub, Erin M.</au><au>Bucobo, Juan Carlos</au><au>Buscaglia, Jonathan M.</au><au>Li, Ellen</au><au>Miller, Joshua D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2020-05-08</date><risdate>2020</risdate><volume>10</volume><issue>1</issue><spage>7793</spage><epage>7793</epage><pages>7793-7793</pages><artnum>7793</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Background: Diabetes is associated with an increased risk of colorectal cancer (CRC). We conducted a retrospective analysis of adenoma detection rates (ADR) in initial screening colonoscopies to further investigate the role of diabetes in adenoma detection. Methods: A chart review was performed on initial average risk screening colonoscopies (ages 45–75) during 2012–2015. Data collected included basic demographics, insurance, BMI, family history of CRC, smoking, diabetes, and aspirin use. Multivariable generalized linear mixed models for binary outcomes were used to examine the relationship between diabetes and variables associated with CRC risk and ADR. Results: Of 2865 screening colonoscopies, 282 were performed on patients with type 2 diabetes (T2DM). Multivariable analysis suggested that T2DM (OR = 1.49, 95% CI:1.13–1.97, p = 0.0047) was associated with an increased ADR, as well as smoking, older age, higher BMI and male sex (all p < 0.05). For patients with T2DM, those not taking diabetes medications were more likely to have an adenoma than those taking medication (OR = 2.38, 95% CI:1.09–5.2, p = 0.03). Conclusion: T2DM has an effect on ADR after controlling for multiple confounding variables. Early interventions for prevention of T2DM and prescribing anti-diabetes medications may reduce development of colonic adenomas and may contribute to CRC prevention.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32385343</pmid><doi>10.1038/s41598-020-64344-2</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-2322 |
ispartof | Scientific reports, 2020-05, Vol.10 (1), p.7793-7793, Article 7793 |
issn | 2045-2322 2045-2322 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7210255 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | 692/163/2743/137 692/4020/1503/1504/1885 Adenoma Adenoma - complications Adenoma - diagnosis Adenoma - epidemiology Aged Aspirin Colonoscopy Colonoscopy - methods Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - complications Colorectal Neoplasms - diagnosis Colorectal Neoplasms - epidemiology Demography Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Early Detection of Cancer Female Genetics Humanities and Social Sciences Humans Male Mass Screening Middle Aged multidisciplinary Neoplasm Staging Odds Ratio Prevention Science Science (multidisciplinary) Smoking Tumors |
title | Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T14%3A00%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%202%20diabetes%20impacts%20colorectal%20adenoma%20detection%20in%20screening%20colonoscopy&rft.jtitle=Scientific%20reports&rft.au=Ottaviano,%20Lorenzo%20F.&rft.date=2020-05-08&rft.volume=10&rft.issue=1&rft.spage=7793&rft.epage=7793&rft.pages=7793-7793&rft.artnum=7793&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-020-64344-2&rft_dat=%3Cproquest_pubme%3E2400097799%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2400097799&rft_id=info:pmid/32385343&rfr_iscdi=true |